Progression of Diabetic cardiomyopathy among Type 2 Diabetic Patients: A Review Article | ||||
| Zagazig University Medical Journal | ||||
| Volume 30, Issue 5, August 2024, Page 1768-1774 PDF (561.68 K) | ||||
| Document Type: Review Articles | ||||
| DOI: 10.21608/zumj.2024.286222.3367 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Usama Ahmed Khalil; Ashraf Khalifa Sharaf El Nagar; Essam Adel Abdelrahman; Dina Mosad El-Said 
| ||||
| Internal Medicine Department, Faculty of Medicine, Zagazig university | ||||
| Abstract | ||||
| Background: Insulin resistance, compensatory hyperinsulinemia, and the development of hyperglycemia promote diabetic cardiomyopathy, a subtype of heart disease that develops apart from other cardiac risk factors like hypertension and coronary artery disease (CAD). The prevalence of heart failure symptoms was 19% in people with type 2 diabetes, and the chance of developing heart failure was two to eight times higher in those people. We intended to outline an overview of the Progression of Diabetic cardiomyopathy among Type 2 Diabetic Patients. Conclusion: Diabetes is one of the rare but rapidly increasing causes of cardiomyopathy globally. The condition is a common consequence of diabetes that is responsible for a great deal of death and disability. We provide a synopsis of the several potential pathogenic mechanisms that are now being studied that could lead to diabetes-related cardiomyopathy, including fibrosis, cell signaling disturbance, and left ventricular (LV) hypertrophy. Heart failure develops from these alterations. | ||||
| Keywords | ||||
| Diabetic cardiomyopathy; Progression; Type 2 Diabetic Patients | ||||
|
Statistics Article View: 91 PDF Download: 77 |
||||
